{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T18:35:37Z","timestamp":1781721337018,"version":"3.54.5"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"am","delay-in-days":302,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["K12 EY021475"],"award-info":[{"award-number":["K12 EY021475"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008522","name":"University of Illinois at Chicago","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008522","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UIC CCTS 2019-01"],"award-info":[{"award-number":["UIC CCTS 2019-01"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR002003"],"award-info":[{"award-number":["UL1TR002003"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.ajo.2024.09.028","type":"journal-article","created":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T19:57:00Z","timestamp":1727812620000},"page":"435-449","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Risk Factors for the Development of Ocular Complications in Herpes Zoster Ophthalmicus and Zoster Vaccine Utilization in a Large, Urban Health System"],"prefix":"10.1016","volume":"269","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0978-3526","authenticated-orcid":false,"given":"Ann-Marie","family":"Lobo-Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arya","family":"Kadakia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supriya D.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ajo.2024.09.028_bib0001","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00005792-198209000-00003","article-title":"Population-based study of herpes zoster and its sequelae","volume":"61","author":"Ragozzino","year":"1982","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.ajo.2024.09.028_bib0002","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3851\/IMP2011","article-title":"Antivirals for management of herpes zoster including ophthalmicus: a systematic review of high-quality randomized controlled trials","volume":"17","author":"McDonald","year":"2012","journal-title":"Antivir Ther"},{"issue":"3","key":"10.1016\/j.ajo.2024.09.028_bib0003","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nrmicro3215","article-title":"Molecular mechanisms of varicella zoster virus pathogenesis","volume":"12","author":"Zerboni","year":"2014","journal-title":"Nat Rev Microbiol"},{"issue":"suppl_2","key":"10.1016\/j.ajo.2024.09.028_bib0004","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1093\/infdis\/jiy403","article-title":"Immunobiology of varicella-zoster virus infection","volume":"218","author":"Laing","year":"2018","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.ajo.2024.09.028_bib0005","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.ophtha.2007.10.009","article-title":"Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity","volume":"115","author":"Liesegang","year":"2008","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.ajo.2024.09.028_bib0006","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.ophtha.2016.03.005","article-title":"Epidemiology of herpes zoster ophthalmicus: recurrence and chronicity","volume":"123","author":"Tran","year":"2016","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ajo.2024.09.028_bib0007","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/ICO.0000000000001046","article-title":"Prevalence of ocular manifestations and visual outcomes in patients with herpes zoster ophthalmicus","volume":"36","author":"Szeto","year":"2017","journal-title":"Cornea"},{"issue":"6","key":"10.1016\/j.ajo.2024.09.028_bib0008","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.mayocp.2013.03.014","article-title":"Herpes zoster eye complications: rates and trends","volume":"88","author":"Yawn","year":"2013","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"10.1016\/j.ajo.2024.09.028_bib0009","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/j.ophtha.2007.10.010","article-title":"Anterior segment complications of herpes zoster ophthalmicus","volume":"115","author":"Kaufman","year":"2008","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.ajo.2024.09.028_bib0010","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1016\/j.ophtha.2011.04.002","article-title":"Herpes zoster ophthalmicus: comparison of disease in patients 60 years and older versus younger than 60 years","volume":"118","author":"Ghaznawi","year":"2011","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.ajo.2024.09.028_bib0011","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/S0161-6420(92)31849-4","article-title":"Oral acyclovir for herpes zoster ophthalmicus","volume":"99","author":"Hoang-Xuan","year":"1992","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2024.09.028_bib0012","article-title":"The impact of varicella vaccination on the incidence of varicella and herpes zoster in the united states: updated evidence from observational databases, 1991-2016","author":"Wolfson","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.ajo.2024.09.028_bib0013","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-004833","article-title":"Systematic review of incidence and complications of herpes zoster: towards a global perspective","volume":"4","author":"Kawai","year":"2014","journal-title":"BMJ Open"},{"issue":"9","key":"10.1016\/j.ajo.2024.09.028_bib0014","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1001\/jamaophthalmol.2016.2166","article-title":"Assessment of the Accuracy of Using ICD-9 Codes to Identify Uveitis, Herpes Zoster Ophthalmicus, Scleritis, and Episcleritis","volume":"134","author":"Pimentel","year":"2016","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2024.09.028_bib0015","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ophtha.2012.09.007","article-title":"Incidence of herpes zoster ophthalmicus: results from the Pacific Ocular Inflammation Study","volume":"120","author":"Borkar","year":"2013","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ajo.2024.09.028_bib0016","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ophtha.2019.10.001","article-title":"Incidence rate of herpes zoster ophthalmicus: a retrospective cohort study from 1994 through 2018","volume":"127","author":"Kong","year":"2020","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ajo.2024.09.028_bib0017","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/ICO.0000000000000362","article-title":"Factors associated with age of onset of herpes zoster ophthalmicus","volume":"34","author":"Chan","year":"2015","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.ajo.2024.09.028_bib0018","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1136\/bjophthalmol-2015-307157","article-title":"Herpes zoster ophthalmicus: declining age at presentation","volume":"100","author":"Davies","year":"2016","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2024.09.028_bib0019","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/bjd.19687","article-title":"Incidence of acute complications of herpes zoster among immunocompetent adults in England: a matched cohort study using routine health data","volume":"184","author":"Forbes","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ajo.2024.09.028_bib0020","first-page":"9","article-title":"The nature of herpes zoster: a long-term study and a new hypothesis","volume":"58","author":"Hope-Simpson","year":"1965","journal-title":"Proc R Soc Med"},{"issue":"10","key":"10.1016\/j.ajo.2024.09.028_bib0021","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1212\/WNL.0b013e3182a3516e","article-title":"The global epidemiology of herpes zoster","volume":"81","author":"Yawn","year":"2013","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.ajo.2024.09.028_bib0022","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jinf.2017.06.010","article-title":"Incidence of herpes zoster amongst adults varies by severity of immunosuppression","volume":"75","author":"Schroder","year":"2017","journal-title":"J Infect"},{"issue":"1","key":"10.1016\/j.ajo.2024.09.028_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0950268803001523","article-title":"Gender difference in the incidence of shingles","volume":"132","author":"Fleming","year":"2004","journal-title":"Epidemiol Infect"},{"issue":"1","key":"10.1016\/j.ajo.2024.09.028_bib0024","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jri.2010.11.009","article-title":"Effect of menstrual cycle variation in female sex hormones on cellular immunity and regulation","volume":"89","author":"Weinberg","year":"2011","journal-title":"J Reprod Immunol"},{"issue":"6","key":"10.1016\/j.ajo.2024.09.028_bib0025","first-page":"408","article-title":"Sex and gender impact immune responses to vaccines among the elderly","volume":"30","author":"Fink","year":"2015","journal-title":"Physiology (Bethesda)"},{"issue":"5","key":"10.1016\/j.ajo.2024.09.028_bib0026","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1365-4632.2009.03929.x","article-title":"Eruption severity and characteristics in herpes zoster ophthalmicus: correlation with visual outcome, ocular complications, and postherpetic neuralgia","volume":"48","author":"Nithyanandam","year":"2009","journal-title":"Int J Dermatol"},{"issue":"9","key":"10.1016\/j.ajo.2024.09.028_bib0027","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/j.1442-9071.2010.02352.x","article-title":"Factors affecting visual outcome in herpes zoster ophthalmicus: a prospective study","volume":"38","author":"Nithyanandam","year":"2010","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.ajo.2024.09.028_bib0028","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ajo.2021.02.002","article-title":"Herpes zoster ophthalmicus clinical presentation and risk factors for loss of vision","volume":"226","author":"Niederer","year":"2021","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2024.09.028_bib0029","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1001\/archopht.121.3.386","article-title":"Herpes zoster ophthalmicus in olmsted county, Minnesota: have systemic antivirals made a difference?","volume":"121","author":"Severson","year":"2003","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2024.09.028_bib0030","doi-asserted-by":"crossref","first-page":"226","DOI":"10.5694\/mja2.50554","article-title":"Characteristics, treatment and complications of herpes zoster ophthalmicus at a tertiary eye hospital","volume":"213","author":"Chakrabarti","year":"2020","journal-title":"Med J Aust"},{"issue":"22","key":"10.1016\/j.ajo.2024.09.028_bib0031","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ajo.2024.09.028_bib0032","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1093\/cid\/ciu918","article-title":"Long-term persistence of zoster vaccine efficacy","volume":"60","author":"Morrison","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.ajo.2024.09.028_bib0033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6611a1","article-title":"Surveillance of vaccination coverage among adult populations - United States","volume":"66","author":"Williams","year":"2015","journal-title":"MMWR Surveill Summ"},{"issue":"52","key":"10.1016\/j.ajo.2024.09.028_bib0034","doi-asserted-by":"crossref","first-page":"7231","DOI":"10.1016\/j.vaccine.2017.11.013","article-title":"Herpes zoster vaccine live: A 10 year review of post-marketing safety experience","volume":"35","author":"Willis","year":"2017","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.ajo.2024.09.028_bib0035","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1093\/cid\/cix683","article-title":"Acute retinal necrosis caused by the zoster vaccine virus","volume":"65","author":"Heath","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.ajo.2024.09.028_bib0036","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1001\/archophthalmol.2011.320","article-title":"Acute retinal necrosis after herpes zoster vaccination","volume":"129","author":"Charkoudian","year":"2011","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2024.09.028_bib0037","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/ICB.0000000000000761","article-title":"Acute retinal necrosis associated with herpes zoster vaccination","volume":"15","author":"Menghini","year":"2021","journal-title":"Retin Cases Brief Rep"},{"issue":"6","key":"10.1016\/j.ajo.2024.09.028_bib0038","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/ICO.0000000000001203","article-title":"Reactivation of herpes zoster keratitis with corneal perforation after zoster vaccination","volume":"36","author":"Jastrzebski","year":"2017","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.ajo.2024.09.028_bib0039","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/ICO.0b013e318277acae","article-title":"Reactivation of herpes zoster keratitis in an adult after varicella zoster vaccination","volume":"32","author":"Hwang","year":"2013","journal-title":"Cornea"},{"issue":"22","key":"10.1016\/j.ajo.2024.09.028_bib0040","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","article-title":"Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults","volume":"372","author":"Lal","year":"2015","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.ajo.2024.09.028_bib0041","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","article-title":"Efficacy of the Herpes Zoster subunit vaccine in adults 70 years of age or older","volume":"375","author":"Cunningham","year":"2016","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ajo.2024.09.028_bib0042","doi-asserted-by":"crossref","first-page":"91","DOI":"10.15585\/mmwr.mm6804a4","article-title":"Postlicensure safety surveillance of recombinant zoster vaccine (Shingrix) - United States, October 2017-June 2018","volume":"68","author":"Hesse","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.ajo.2024.09.028_bib0043","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1001\/jama.2019.9053","article-title":"Effect of recombinant zoster vaccine on incidence of herpes zoster after autologous stem cell transplantation: a randomized clinical trial","volume":"322","author":"Bastidas","year":"2019","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.ajo.2024.09.028_bib0044","doi-asserted-by":"crossref","first-page":"80","DOI":"10.15585\/mmwr.mm7103a2","article-title":"Use of recombinant zoster vaccine in immunocompromised adults aged >\/=19 years: recommendations of the Advisory Committee on Immunization Practices - United States","volume":"71","author":"Anderson","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"10.1016\/j.ajo.2024.09.028_bib0045","doi-asserted-by":"crossref","first-page":"844","DOI":"10.3390\/vaccines10060844","article-title":"Prospective, longitudinal study on specific cellular immune responses after vaccination with an adjuvanted, recombinant zoster vaccine in kidney transplant recipients","volume":"10","author":"Lindemann","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"2","key":"10.1016\/j.ajo.2024.09.028_bib0046","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/ICO.0000000000002537","article-title":"Presumed herpes zoster ophthalmicus reactivation following recombinant zoster vaccination","volume":"40","author":"Jabbour","year":"2021","journal-title":"Cornea"},{"key":"10.1016\/j.ajo.2024.09.028_bib0047","article-title":"Uveitis reactivation following recombinant zoster vaccination","volume":"23","author":"Richards","year":"2021","journal-title":"Am J Ophthalmol Case Rep"},{"key":"10.1016\/j.ajo.2024.09.028_bib0048","article-title":"Acute retinal necrosis following recombinant subunit varicella-zoster virus vaccine","volume":"20","author":"Chen","year":"2020","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"3","key":"10.1016\/j.ajo.2024.09.028_bib0049","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jamaophthalmol.2023.6830","article-title":"Risk of herpes zoster ophthalmicus recurrence after recombinant zoster vaccination","volume":"142","author":"Walia","year":"2024","journal-title":"JAMA Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2024.09.028_bib0050","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1016\/j.mayocp.2017.10.009","article-title":"Risk factors for herpes zoster: a systematic review and meta-analysis","volume":"92","author":"Kawai","year":"2017","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"10.1016\/j.ajo.2024.09.028_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.annepidem.2016.04.006","article-title":"Self-reported herpes zoster, pain, and health care seeking in the Health and Retirement Study: implications for interpretation of health care-based studies","volume":"26","author":"Hales","year":"2016","journal-title":"Ann Epidemiol"},{"issue":"1","key":"10.1016\/j.ajo.2024.09.028_bib0052","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2023.2176065","article-title":"Public health impact of herpes zoster vaccination on older adults in Hong Kong","volume":"19","author":"Chan","year":"2023","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"10.1016\/j.ajo.2024.09.028_bib0053","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/ceo.13340","article-title":"Using natural language processing for identification of herpes zoster ophthalmicus cases to support population-based study","volume":"47","author":"Zheng","year":"2019","journal-title":"Clin Exp Ophthalmol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939424004562?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939424004562?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T20:00:47Z","timestamp":1777406447000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939424004562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":53,"alternative-id":["S0002939424004562"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2024.09.028","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk Factors for the Development of Ocular Complications in Herpes Zoster Ophthalmicus and Zoster Vaccine Utilization in a Large, Urban Health System","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2024.09.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}